Oncopharmpod
Monthly Immunotherapy Expanded Approvals Update
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:14:57
- Mas informaciones
Informações:
Sinopsis
Another month, another 2 expanded FDA-approvals: nivolumab/ipilimumab for malignant pleural mesothelioma and pembrolizumab for relapsed/refractory classical Hodgkin's lymphoma.
